Mycobiome analyses of critically ill COVID-19 patients
D. Weaver, S. Gago, M. Bassetti, D. R. Giacobbe, J. Prattes, M. Hoenigl, F. Reizine, H. Guegan, J.-P. Gangneux, M. J. Bromley, P. Bowyer
This study analyzes the respiratory mycobiome of critically ill COVID-19 patients to identify fungal signatures linked to mortality and antifungal drug use.
bioRxiv · Jun 13, 2023Microbiology